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INTRODUCTION 
 
Acute pancreatitis is an inflammatory disease  ranging   from mild self- limiting course  
to a fulminant phase  with multiple organ failure and  mortality. It occur in two forms, 
80% of patients develops  edematous pancreatitis and 20% manifest as acute necrotising 
pancreatitis.  The average mortality rate for edematous type is <1% and necrotising type 
ranges from 10-20% (Banerjee et al.1995 ). Patients with mild type managed with 
aggressive fluid resuscitation and supportive care. Severe AP may require maximal non 
operative care and nutritional support. Severe AP is divided into two-phase systemic 
disease. In the early phase ( Within initial 2 weeks)   development of pancreatic 
inflammation and  necrosis, followed by systemic inflammatory response syndrome 
(SIRS) ultimately  leading  to multiple organ dysfunction syndromes (MODS) . Mortality 
is high due to MODS. (Health et al.1995). If the early phase is not corrected  by  
therapeutic intervention, then  late phase occurs  after the second week of onset, and 
includes the formation of infected pancreatic necrosis or fluid collection with possible 
progression to overt sepsis, MODS and death. Organ failure is present in only half of the 
patients with pancreatic necrosis. The mortality rate for MODS ranges from 30 to 100% 
(Neoptolemos et al.1998).  Respiratory failure is the most common type of organ failure 
in AP (Viedma et al.1994).  Increasing knowledge of the  importance of  
proinflammatory and anti-inflammatory cytokine helps in development of   anti-
inflammatory therapy which is  beneficial.   
11 
 
 
 
 
 
 
 
 
                           REVIEW OF LITERATURE 
  
 
 
 
 
 
 
12 
 
 
HISTORY & BACKGROUND: 
The definition and classification of pancreatitis is characterized mainly by the 
distinction between acute and chronic pancreatitis as stated by Lagerlof in 1942 
(Lagerlof,1942). These two clinical conditions seems to be different pathologic 
processes. But with the help of imaging studies, particularly magnetic resonance 
imaging (MRCP), the classic distinction between acute and chronic pancreatitis is 
clearly made. 
  
The mechanism causing fibrosis in the glandular tissue begins with acute abdominal 
pain with increase levels of serum amylase and lipase. Acute pancreatitis developing 
into chronic pancreatitis due to obstruction secondary to edema or inflammatory 
response of the sphincter of Oddi.  
 
The most typical natural history regarding the correlation between acute and 
chronic pancreatitis is so-called recurrent pancreatitis. It is not possible to define this 
condition per se, but it represents the best example of the new comprehension of the 
pathologic process. Nevertheless, today we must keep in mind a classification of acute 
and chronic pancreatitis to help in developing diagnostic and therapeutic algorithms. 
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ANATOMY – PANCREAS 
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 The pancreas, derived from GREEK (pan-all; kreas – flesh) lies in the upper left part of 
the abdomen. It is found behind the stomach. The pancreas is about 6 inches long. 
Anatomically the pancreas is divided into the head, neck, body and tail. The head is 
surrounded by duodenum in its concavity. Uncinate process  arise from the back of head. 
The neck is 2.5 cms long and lies infront of the superior mesenteric artery and vein. The 
body is the largest part of the pancreas and lies behind the pylorus. The tail ends by 
abutting the spleen. 
The pancreas is the secretory structure with an internal hormonal role (ENDOCRINE) 
and an external digestive role (EXOCRINE). It has two main ducts, MAIN 
PANCREATIC DUCT and ACCESSORY PANCREATIC DUCT. These drain enzymes 
through the ampulla of vater into the duodenum. 
The pancreas receive blood supply from the celiac artery and superior mesenteric artery. 
The splenic artery supplies the neck, body and tail through its pancreatic branches. The 
head is supplied by superior & inferior pancreaticoduodenal arteries and drains into the 
superior mesenteric and portal veins. The body and neck drains into splenic vein. 
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BLOOD SUPPLY OF PANCREAS 
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HISTOLOGY OF THE PANCREAS 
         
The pancreas contains tissue with an endocrine and exocrine role. The tissues with 
endocrine role be seen under staining as lightly stained clusters of cells, called 
PANCREATIC ISLETS OF LANGERHANS. Darker staining cells form clusters called 
ACINI. The secretory cells of each acinus surround a small INTERCALATED DUCT. 
The intercalated ducts drain into larger ducts within the lobule, and finally interlobular 
ducts. The ducts are lined by a single layer of columnar epithelium. 
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                                HISTOLOGY OF PANCREAS 
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CLASSIFICATION OF ACUTE PANCREATITIS: 
The classifying systems for  acute pancreatitis comes under following tables 
ATLANTA CLASSIFICATION 
Based on Atlanta classifying system, acute pancreatitis is divided into: 
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INTERNATIONAL CLASSIFICATION: 
i) Acute pancreatitis 
a) Mild 
b) Severe 
ii) Acute interstitial pancreatitis 
iii) Acute necrotizing pancreatitis 
a) Infected 
b) Sterile 
iv) Pancreatic abscess 
v) Pseudocyst pancreas 
vi) According to clinico anatomical types 
a) Haemorrhagic 
b) Fatty 
c) Edematous 
vii) According to necrotic distribution 
a) Focal 
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b) Diffuse 
 
 
 
CAMBRIDGE CLASSIFIATION of PANCREATITIS: 
 Acute 
 Chronic 
 
 
                  MANCHESTER CLASSIFICATION: 
1. Mild 
2. Moderate 
3. End stage 
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MARSEILLE CLASSIFICATION: 
i) Acute  
ii) Chronic 
iii) Chronic inflammatory 
  
REVISED MARSEILLE CLASSIFICATION: 
 Acute 
 Chronic 
 Obstructive chronic types. 
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ETIOPATHOGENESIS  OF ACUTE PANCREATITIS 
 Pancreatitis, an inflammatory disorder  caused  by increased intakeof alcohol  
or the migration of gallstones. The tabular column shows the etiology of pancreatitis:  
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                                PATHOGENESIS OF ACUTE PANCREATITIS 
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EtioPathogenesis of Biliary Pancreatitis: 
The incidence of cholelithiasis induced pancreatitis is 30%. The prevalence of gallstones 
is 18.8% (Volzke et al, 2005).  Male/Female ratio ranges from 1: 1.7 to 1: 1.4, suggesting 
that men are at a greater risk of developing biliary pancreatitis than women. Above  60 
years  of age, the age risk  was reversed; more women than men had biliary pancreatitis 
(Imrie & Blumgart, 1975). 
The socioeconomic impact of gallstone disease remains one of the highest in 
gastroenterology, in spite of the fact that the risk of developing pancreatitis remains < 1% 
for gallstone carriers. 
Eugene  Lindsay Opie, first to address biliary pancreatitis. In 1901, he reported two post-
mortem reports and he concluded that two characteristic mechanisms exist for gallstone-
induced pancreatitis (Opie, 1901a, 1901b). The first case showed that an impacted 
gallstone occludes the orifice of the Wirsung duct causing  acute pancreatitis (Opie, 
1901a). When Opie simulated this finding by pancreatic duct ligation in animals, he 
proposed the pancreatic outflow obstruction and named as “Impaired outflow 
hypothesis”. 
In second case, the impacted stone at duodenal papilla  created a communication between 
the common bile duct and the wirsung duct  permiting  the infected bile to enter the 
pancreatic duct. Opie proposed this triggering mechanism as “common channel 
hypothesis”. 
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FIGURE 1. CT ABDOMEN IMAGE SHOWING INFLAMMED PANCREAS WITH 
PERIPANCREATIC FAT STRANDING 
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    MECHAMISM OF ALCOHOLIC PANCREATITIS : 
Alcohol abuse is the second most important cause of acute pancreatitis. Most 
patients with acute pancreatitis of this etiology drink at least 100 g of alcohol per day 
for long periods. Honest information from the patient can be difficult to obtain, and 
it is important to question relatives and close friends. Measurement of blood alcohol 
levels can be helpful. Alcohol is the most common etiology in prospective studies 
from New York and Helsinki (Ranson et al, 1974; Saino et al, 1995). In each study, 
approximately 75% to 80% of patients had alcohol abuse as the etiology with a 
young median age of around 40 years compared with the common median age for 
biliary etiology of 53 years. The exact mechanism by which alcohol induces acute 
pancreatitis is uncertain, but possible that cigarette smoking is also a factor because 
most of these patients smoke 20 or more cigarettes daily. Alcohol cause spasm of the 
sphincter of Oddi, and acute alcohol ingestion increases human pancreatic 
bicarbonate and protein secretion, whereas chronic intake decreases bicarbonate 
secretion and increases the viscosity of pancreatic juice so that it contains a higher 
concentration of proteins. 
 The relationship between acute and chronic pancreatitis in patients who regularly 
abuse alcohol is uncertain. The duration between the onset of alcohol intake and 
occurrence of symptoms ranges from 7 to 29 years. 
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    EFFECTS OF ETHANOL IN PANCREAS: 
1. Direct pancreatic acinar injury 
2. Alcohol induced elevation of serum lipids, fatty acids and ethyl ester metabolites 
causing pancreatic injury. 
3. Formation of pancreatic juice which contains high enzymatic activity cause 
enzyme activation, precipitation of proteins leading to intraductal plug formation 
and obstruction causing pancreatic injury. 
4. Alcohol cause sphincter of Oddi dysfunction leading into pancreatic ductal 
obstruction and ends in pancreatitis. 
5. Pancreatic injury caused by release of free O2 radicals. 
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FIGURE2. CT ABDOMEN CONTRAST SHOWING EDEMATOUS 
PANCREATITIS. 
 
 
 
 
INFLAMMED PANCREAS 
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EtioPathogenesis of Nonbiliary  and Nonalcoholic Pancreatitis: 
.  
Hyperlipidemia 
 Acute pancreatitis presents usually with varying degrees of severity such as infected 
necrosis and pseudocyst formation, which also occurs in hypertriglyceridemia patients. 
According to Fortson (1995), patients with hyperlipidemic patients fulfills  the following  
criterias to develop pancreatitis, they are  patients whose is hyperglycaemic and out of 
control, alcoholic patients with hyperlipidaemia, euglycaemic, lean and non-alcoholic 
patients with hypertriglyceridemia caused by medication or nutrition; or patients with 
familial hypertriglyceridemia. 
The diagnosis of acute hyperlipidemic pancreatitis is based on serum and urinary lipase 
levels which remains within the above normal limits. (Lesser & Warshaw, 1975). The 
reason for this phenomenon reveals that there is   an interference of the test assay with the 
plasma lipids or an unknown amylase inhibitor in plasma and urine that impairs the 
assay. This inhibitor has not been identified so far. In initial days the diagnostic 
parameter of hyperlipidemic pancreatitis was significant increase in ratio of urinary 
amylase and creatinine. (Warshaw et al, 1975). Triglycerides are above 1000 mg/dL, and 
therapy includes enteral nutrition regimens.  Extracorporeal lipid reduction therapy 
should be considered in patients if triglyceride level does not reduce. 
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Drug-Induced Pancreatitis: 
According to World Health Organization (WHO) list of 525 drugs published that cause 
acute pancreatitis. The overall incidence ranges from 0.1% and 2% of pancreatitis per 
cases. Drugs like mesalazine, azathioprine and simvastatine carries high adverse effects 
of developing acute pancreatitis. But the underlying pathophysiologic mechanisms 
remains sparse and  the disease course is usually mild or even subclinical (Nitsche et al, 
2010). 
Infectious Causes: 
VIRAL ILLNESS: 
 The incidence of acute pancreatitis in infectious patients was less than 2%. 
The most frequent association of a viral infection with acute pancreatitis is mumps. The 
incidence of pancreatitis in mumps patient (parvovirus B19) is 0.3% to 14%. Acute 
pancreatitis mainly occurs 2 weeks after the initial onset of disease. Sometimes acute 
pancreatitis may occur 1 week prior to parotitis.  The disease is usually mild, symptoms 
persist only 3 to 7 days. Serum lipase activity is elevated. Amylase measurements also 
elevated but results in an incorrect diagnosis due to increased activity from affected 
salivary gland. No specific treatment is available.  
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The second most common viral infection associated with pancreatitis is coxsackie virus 
B.  The incidence of acute pancreatitis in coxsackie virus ranges from 0% to 11%. 
(Parenti et al, 1996). Other viruses such as Hepatitis virus A, B, or C also   cause acute 
pancreatitis. In mild form of acute hepatitis, an increase in amylase activity can be 
detected in upto 30% of patients. In severe and ultimately lethal patients, post-mortem 
report shows 44% of patients with acute pancreatitis.  
Post mortem studies also reported incidence of pancreatitis in 50% of patients who died 
from AIDS. Other virus infections like Epstein-Barr virus, rubella, adenovirus, rubeola, 
herpes simplex virus, rotavirus also cause pancreatitis.  
  
 
BACTERIAL CAUSES: 
 Bacterial infections causing acute pancreatitis, such as Yersinia enterocolitica and Y. 
pseudotuberculosis, Salmonella enteritis and  S.typhimurium, Campylobacter jejuni, and 
Mycoplasma pneumoniae. Acute pancreatitis induced by a Campylobacter is a rare. 
Amylase and lipase levels elevated three to six times above normal and the disease course 
is mild. 
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PARASITIC CAUSES: 
Parasites causing  acute pancreatitis includes ascariasis and clonorchis sinensis.  The 
ascariasis is the most common type of helminthic infection in humans. An endemic 
manifestation is found mainly in tropical and subtropical countries. The  mechanism 
causing pancreatitis includes  worms migrates  from intestines to either the biliary or 
pancreatic ducts, leading to obstruction causing pancreatitis. The disease can be 
diagnosed by ultrasonography or endoscopic retrograde cholangiopancreatography 
(ERCP). The appropriate treatment is a combination of antihelminthic therapy with 
standard treatment for acute pancreatitis.   
The Chinese liver fluke Clonorchis sinensis also cause pancreatitis in which it lodges  in  
the biliary tract.  C. sinensis infection also causes periductal fibrosis, adenomatous 
proliferation and squamous metaplasia causing obstruction and results  in acute 
pancreatitis. 
 
ERCP related Pancreatitis: 
 Endoscopic retrograde cholangiopancreaticography is the imaging modality in various 
hepato biliary pancreatic disease. It is used for both diagnostic  and therapeutic purposes 
in hepato biliary pancreatic tree.  The most common complication  is procedure-related 
acute pancreatitis, occurs in 2% to 9% of individuals. It ranges from mild variant with 
complete recovery to severe disease with prolonged hospitalisation, pancreatic necrosis, 
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multiorgan failure and even death. About 10% of patients have tendency to develop 
complications  and up to 1% have fatal course (Freeman, 2001). The mechanism includes 
increase pressure in the pancreatic duct, chemical injury from the injection of contrast 
media which leads to initiation of  inflammatory cytokine release and protease activation 
cascade  that ultimately results in  disease. Individuals with  low pH of 6.9 in contrast 
media cause  activation of the α-cation channel expressed on C and Aδ fibers of primary 
sensory neurons called transient receptor potential vanilloid 1 (TRPV1) neurons results in 
pancreatitis. 
 
 
HEREDITARY CAUSES  OF  PANCREATITIS: 
Patients with unknown cause for pancreatitis comes under idiopathic pancreatitis. 
Hereditary pancreatitis is a rare entity with tendency to occur before 20 years of age and 
progress to develop chronic pancreatitis for next 20 years and finally leads to pancreatic 
cancer at 70 years. Mutations associated are R122H, N291 and A16v of cationic 
trypsinogen gene. Other mutations include cystic fibrosis transmembrane conductance 
regulator and intracellular trypsin inhibitor (KAZAL, type I). No treatment is available 
yet.   
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DIAGNOSIS OF ACUTE PANCREATITIS 
CLINICAL PRESENTATION: 
Patient presents with sudden-onset of upper abdominal pain and vomiting.. The 
location of the pain may be in the epigastrium or right or left upper quadrant of the 
abdomen radiating towards to the back. An encircling upper abdominal pain is less 
common.  Severe pain is often present for the initial 48 hours, which then settles 
over the next 96 hours. The accompanying vomiting exacerbates the tendency to 
hypovolemia and hypotension. A mild degree of obstructive jaundice may be 
present, and occasionally cholangitis co-exists with acute pancreatitis. Bowel sounds 
may be present at the time of initial presentation, but frequently a degree of paralytic 
ileus occurs. Despite this paralytic ileus, early enteral feeding either by the 
nasojejunal or the nasogastric route can be routinely practiced (Eatock et al, 2005). 
Mild acute pancreatitis usually resolves fairly quickly with simple treatment 
measures.  Other clinical findings, such as ecchymosis of the flank (Grey Turner 
sign) or periumbilical area (Cullen sign) are noted.  
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BIOCHEMICAL ANALYSIS: 
Serum Amylase & Lipase 
 Diagnosis of acute pancreatitis is confirmed by measuring the serum amylase and lipase 
values. An elevated  serum amylase value 3 times than its normal value and lipase level 2 
times more than its normal value confirms the diagnosis. But comparing these two 
parameters, Serum lipase high sensitivity and specificity than serum amylase since 
amylase level increases in other acute inflammatory conditions. The normal value of 
serum amylase and lipase is 40-140U/L and 0-160 U/L.  
C-Reactive Protein 
 C-reactive protein (CRP) is a non specific biomarker for inflammation. It is synthesised 
by release of inflammatory cytokines. Serum concentration of >150 mg/L  predicts the 
severity of the disease  with high sensitivity.  
 
Trypsinogen  Activation Peptide 
Trypsinogen activation peptide (TAP) level elevation in urine and plasma helps in 
detecting the severity of acute pancreatitis.  Due to unavailability of  the TAP test kit it  is 
withdrawn. An automated assay technique is needed for clinical practise.  
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Hematocrit  
 Packed cell volume or Hematocrit, a  prognostic tool  for assessing  the severity of acute 
pancreatitis.  A hematocrit of > 44%  indicates pancreatic necrosis  and multiorgan 
failure.(Brown et al, 2000). This is mainly due to the third space fluid loss. 
 
Procalcitonin  
Procalcitonin(PCT), which is the precursor of calcitonin, new serum marker used in 
detecting acute pancreatitis. The synthesis and release of PCT mediated by 
proinflammatory cytokines and lipopolysaccharides. To differentiate mild and severe 
type of acute pancreatitis, PCT rapid semiquantitative assay is used. 
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Imaging Assessment of Acute Pancreatitis  
The radiological investigation of choice is dynamic contrast enhanced computed 
tomography scan.  It has high sensitivity and accuracy rate in detecting the severity of 
acute pancreatitis. 
 
 
The following table shows the BALTHAZAR CT scoring system for predicting the 
severity:  
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TABLE SHOWING CT FINDINGS IN COMPLICATED TYPES OF ACUTE 
PANCREATITIS: 
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FIGURE SHOWING ACUTE NECROTISING PANCREATITIS WITH 
PERIPANCRATIC COLLECTION 
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FIGURE SHOWING ACUTE NECROTISING PANCREATITIS 
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FIGURE SHOWING WALLED OFF PANCREATITIS 
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FIGURE SHOWING PSEUDOCYST FORMATION IN ACUTE PANCREATITIS 
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Though the imaging modality of choice is CECT scan, MRI may also helps in delineating 
the vein thrombosis and pseudoaneurysm in severe pancreatitis. MRI also plays a role in 
delineating the anatomical orientation of pancreas. 
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FIGURE SHOWING MRI IMAGE OF ACUTE PANCREATITIS 
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DISEASE OF SEVERIY ASSESSMENT 
49 
 
To identify the cause and severity in a particular episode of pancreatitis it is important 
to identify the group with maximum risk of death and main complications. To identify 
this group, numerous grading systems have been devised. An initial system (Ranson et 
al,1974) was more relevant to patients with alcohol-associated disease. Ranson 
subsequently introduced a modified grading system for patients with biliary disease 
(Ranson, 1979). This modification has complicated the system because a dilemma 
exists as to which to use when the patient is initially admitted. There has not been a 
problem with the Glasgow grading system, which has been increasingly used in the 
United Kingdom and elsewhere (Imrie et al, 1978; Osborne et al, 1981; Wilson et al, 
1988). The system comprises eight factors; the presence of any three or more within 48 
hours of admission defines the patient as having severe disease .  
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The single biomarker for detecting the clinical severity, C- Reactive protein level. The 
normal value is 10mg/L and the value >150mg/L indicates severe disease. Other 
biochemical markers includes IL-8,IL-6, TNF soluble receptors, polymorphonuclear 
elastase, serum procalcitonin, soluble IL-2 receptors and soluble E- selectin. 
Trypsinogen activation peptide is an additional marker useful in determining the 
prognosis.              
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CLINICAL SCORING SYSTEMS 
 Clinical scoring systems  such as  Ranson which contains  11 biochemical criteria, 
Glasgow  and  Acute physiology and chronic health evaluation  2 score contains 12 
biochemical variables are used to predict outcomes in acute pancreatitis. 
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APACHE II SCORING SYSTEM: 
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RANSON SCORING SYSTEM
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COMPLICATION OF ACUTE PANCREATITIS 
i. Shock 
ii. Septicaemia 
iii. Elevated serum calcium 
iv. Acute kidney injury 
v. Disseminated intravascular coagulation 
vi. Pleural effusion 
vii. Pseudoaneurysm in pancreas 
viii. Pancreatic abscess 
ix. Chronic pancreatitis 
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MANAGEMENT: 
I. CONSERVATIVE  MANAGEMENT: 
SIRS PHASE: 
Aggressive fluid  resuscitation in order to replenish extravascular or third space fluid loss. 
To maintain the intravascular volume, fluid flow rate of >200mL/h is recommended.  
Close monitoring , intravenous fluid supplementation  and pain relief  are most important. 
Crystalloid resuscitation volumes as high as 20 L may e required. 
COUNTERACTIVE ANTIINFLAMMATORY RESPONSE SYNDROME PHASE: 
During this phase, fatal complications have to be ruled out if the patient deterioates from 
the initial phase. 
 
PREVENTION OF INFECTION: 
Enterogenous bacteria is the most common cause for infections. Systemic intravenous 
antibiotics, enteral nutrition and probiotics are used to prevent infection. 
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II. INTERVENTIONAL TREATMENT: 
SYSTEMIC INFLAMMATORY RESPONSE SYNDROME PHASE ( FIRST & 
SECOND WEEKS) 
Intervention in this phase aims to prevent fatal complications or further deterioration. 
Currently the intervention is ENDOSCOPIC RETROGRADE 
CHOLANGIOPANCREATOGRAPHY with SPHINCTEROTOMY. 
 
INDICATIONS FOR ACUTE INTERVENTIONS: 
1. Abdominal compartment syndrome 
2. Bowel ischaemia 
3. Perforation 
4. Severe bleeding unresponsive to angiographic coiling. 
 
 
61 
 
 
INTERVENTION IN THE SECOND COUNTERACTIVE 
ANTIINFLAMMATORY RESPONSE SYNDROME PHASE: 
 
INDICATIONS ARE: 
1. Gastric outlet  obstruction 
2. Bowel perforation  
3. Bleeding 
4. Abdominal compartment syndrome 
The surgical management of choice is OPEN LAPAROTOMY WITH 
NECROSECTOMY and minimally invasive procedures (PERCUTANEOUS, 
ENDOSCOPIC and LAPAROSCOPIC TECHNIQUES) 
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AIMS & OBJECTIVES 
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AIMS OF THE STUDY: 
 
 
1. To correlate and analyse the various clinical presentations of acute pancreatitis. 
2. To predict the severity of acute pancreatitis with available clinico biochemical 
parameters. 
3. To assess the severity in relation to serum C REACTIVE PROTEIN. 
4. To prognosticate and assess the severity of the disease. 
5. To predict the outcome of acute pancreatitis with regard to serum CRP. 
 
 
 
 
 
 
 
64 
 
 
 
 
 
MATERIALS & METHODS: 
54 patients are included in this study who presented with acute pancreatitis in the 
department of surgical emergency, Thanjavur medical college during the period of 
October 2015- August 2016. 
STUDY DESIGN: 
Prospective study from October 2015- August 2016.  
INCLUSION CRITERIA: 
Patients diagnosed as acute pancreatitis irrespective of sex and age over 25 years. 
EXCLUSION CRITERIA: 
1. Patient age <25 years. 
2. Patient diagnosed as chronic pancreatitis. 
3. Withdrawl / refusal to consent 
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DIAGNOSTIC CRITERIA: 
Acute pancreatitis is diagnosed clinically and biochemically with elevated serum 
amylase value above the upper reference limit. The diagnosis is further confirmed 
by PLAIN X-RAY ABDOMEN, USG and CONTRAST ENHANCED CT SCAN. 
 
 
MATERIALS USED ARE: 
I. Serum CRP and Serum Amylase 
II. Serum electrolytes 
III. Arterial blood gas analysis 
IV. CBC and urine investigations 
V. Serum creatinine and urea. 
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OBSERVATION & DISCUSSION 
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ANALYSIS AND OBSERVATIONS: 
1. RELATIONSHIP of AGE AND SEX IN ASSESSING THE DISEASE: 
   A total of 54 patients incorporated in this study. Among them 47 are males and 7 are 
females. The average age of occurrence of the disease is 31 to 40 years which is shown in 
the following tables and charts. 
I.TABLE SHOWING AGE PREPONDERANCE (Frequency Table) 
 
   
Particulars 
No.of respondents 
(n=54) 
Percentage 
(100%) 
Below 30yrs 11 20.4 
31 to 40yrs 20 37.0 
41 to 50yrs 13 24.1 
51 to 60yrs 5 9.3 
61yrs & above 5 9.3 
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A. AGE CHART 
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                             II. TABLE SHOWING SEX PREPONDERANCE   
                                                                             
Particulars 
No.of respondents 
(n=54) 
Percentage 
(100%) 
Male 47 87.0 
Female 7 13.0 
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                  B.  DIAGRAM SHOWING GENDER FREQUENCY  
 
 
Male, 87
Female, 13
Male Female
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                      III. TABLE SHOWING DISCHARGE/ DEATH/AMA 
 
Particulars 
No.of respondents 
(n=54) 
Percentage 
(100%) 
Discharges  50 92.6 
AMA 2 3.7 
Death 2 3.7 
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C.GRAPH SHOWING % OF DISCHARGE/DEATH/AGAINST MEDICAL 
ADVICE(AMA)  
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2. RELATIONSHIP OF SERUM AMYLASE, SERUM CRP AND APACHE II 
SCORE: 
 
                       A total of 54 patients studied in this study. The following table (4,5,6) 
shows the serum biomarkers and scoring system values in both mild and severe 
pancreatitis patients. 
 
IV. TABLE SHOWING SERUM AMYLASE LEVEL IN MILD & SEVERE 
DISEASE 
 
Particulars 
No.of respondents 
(n=54) 
Percentage 
(100%) 
Below 1000 45 83.3 
Above 1000 9 16.7 
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D.GRAPH SHOWING % OF SERUM AMYLASE IN MILD AND SEVERE 
DISEASE  
 
 
83.3
16.7
0
10
20
30
40
50
60
70
80
90
Below 1000 Above 1000
75 
 
V. TABLE SHOWING FREQUENCY OF APACHE II SCORE 
 
Particulars 
No.of respondents 
(n=54) 
Percentage 
(100%) 
Below 8 26 48.1 
Above 8 28 51.9 
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E.GRAPH SHOWING APACHE II SCORE IN MILD AND SEVERE DISEASE 
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VI. TABLE SHOWING % OF SERUM CRP 
 
Particulars 
No.of respondents 
(n=54) 
Percentage 
(100%) 
Below 150 22 40.7 
Above 150 32 59.3 
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F.PIE CHART SHOWING SERUM CRP IN MILD AND SEVERE DISEASE  
 
Below 150, 40.7
Above 150, 59.3
Below 150 Above 150
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3. RELATIONSHIP BETWEEN CLINICAL SCORING AND BIOCHEMICAL 
MARKERS: 
     
   It is found in this study that there is a linear progression between the 
biochemical marker and scoring system by comparing the statistical inference as 
shown in the following tables and charts. 
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VII. TABLE SHOWING DESCRIPTIVE  STATISTICS 
 
 N Min. Max. Mean  S.D 
AGE 54 26 71 41.33 11.237 
SR. AMYLASE IU/L 54 154 1520 603.26 359.472 
APACHEII score 54 3 28 9.54 4.875 
SR. CRP mg/L 54 68 198 139.39 26.992 
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VIII. TABLE SHOWING T-Test AND ITS SIGNIFICANCE 
 
PARAMETER n Mean  S.D t df Statistical inference  
SR. AMYLASE IU/L       
Below 1000 45 134.78 27.178 -3.014 52 .004<0.05 
Above 1000 9 162.44 6.821   Significant  
APACHEII score       
Below 8 26 122.81 26.883 -5.374 52 .000<0.05 
Above 8 28 154.79 15.822   Significant  
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IX. TABLE COMPARING Chi-SQUARE TEST AND ITS SIGNIFICANCE OF 
BOTH SERUM AMYLASE AND APACHE II SCORE WITH SERUM CRP 
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SR. CRP mg/L 
Statistical 
inference 
Below 150 Above 150 Total 
n % n % n % 
SR. AMYLASE 
IU/L 
       
Below 1000 22 100.0% 23 71.9% 45 83.3% X2=7.425 Df=1 
.006<0.05 
Significant  
Above 1000 0 .0% 9 28.1% 9 16.7% 
APACHEII score        
Below 8 19 86.4% 7 21.9% 26 48.1% X2=21.717 Df=1 
.000<0.05 
Significant 
Above 8 3 13.6% 25 78.1% 28 51.9% 
Total 22 100.0% 32 100.0% 54 100.0%  
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X. TABLE COMPARING Chi-square test OF SERUM AMYLASE AND SERUM 
CRP WITH APACHE II SCORE  
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APACHEII score 
Statistical 
inference 
Below 8 Above 8 Total 
n % n % n % 
SR. AMYLASE 
IU/L 
       
Below 1000 24 92.3% 21 75.0% 45 83.3% X2=2.908 Df=1 
.088>0.05 
Not Significant  
Above 1000 2 7.7% 7 25.0% 9 16.7% 
SR. CRP mg/L        
Below 150 19 73.1% 3 10.7% 22 40.7% X2=21.717 Df=1 
.000<0.05 
Significant 
Above 150 7 26.9% 25 89.3% 32 59.3% 
Total 26 100.0% 28 100.0% 54 100.0%  
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XI. TABLE COMPARING Chi-square test OF SERUM CRP AND APACHE II 
SCORE WITH SERUM AMYLASE 
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AMYLASE IU/L 
Statistical inference Below 1000 Above 1000 Total 
n % N % N % 
SR. CRP mg/L        
Below 150 22 48.9% 0 .0% 22 40.7% X2=7.425 Df=1 
.006<0.05 
Significant  
Below 150 23 51.1% 9 100.0% 32 59.3% 
APACHEII score        
Below 8 24 53.3% 2 22.2% 26 48.1% X2=2.908 Df=1 
.088>0.05 
Not Significant 
Above 8 21 46.7% 7 77.8% 28 51.9% 
Total 45 100.0% 9 100.0% 54 100.0%  
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STATISTICS METHOD: 
Results were expressed as mean±SE. Statistical analyses were made using Student t test, 
Chi square test. P value < 0.05 were accepted as statistically significant. 
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RESULTS: 
 
 Among 54 patients, 32 had severe disease and  22 had mild disease based on serum CRP 
(P<0.05).  Serum amylase and Apache ii scoring system were analysed on the first day of 
admission. Serum  CRP taken at 48 hours of admission. The  average age of occurrence 
31 to 40 years. Males are more commonly affected than females. Alcohol was the leading 
cause of death in both mild and severe disease. In this study upper limit for serum 
amylase were 1000U/L, Apache II score >8 and serum CRP >150mg/L. The percentile of 
patients for mild and severe pancreatitis for serum amylase, Apache ii score and serum 
CRP includes 83.8%, 48%, 40.7% and 16.7%, 51.9%, 59.3%. The standard deviation of 
serum amylase, Apache ii score and serum CRP includes 359.472, 4.875, 26.992.  The 
statistical inference of all the three parameters comparing one value with other 
parameters shows serum CRP has significant value of P<0.05.  Among the 32 patients 
with severe disease, two patients died after developing multiple organ failure. Others had 
pancreatic necrosis, renal and respiratory failure.  
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FOLLOW UP: 
                      Out of 54 patients, 50 patients are discharged, 2 patients died and 2 patients 
went on against medical advice. Among the 50 patients, 20 patients did not turn up for 
follow up. It was found that 16 of 20 patients who had alcoholic pancreatitis had 
recurring episodes and had repeated hospital admissions.  About 4 out of 20 patients who 
had biliary pathology had recurred and these were due to retained calculi in biliary tract. 
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CONCLUSION: 
 
1. Serum CRP is the important single prognostic marker of predicting the severe 
pancreatitis with the cut off value of 150mg/L. 
2. CRP levels increase significantly in early stages of pancreatic necrosis. 
3. CRP plays a critical role in initial process of diagnosis, as an early predictive 
indicator of severity of the disease and helps in detecting the mortality in this 
study. 
4.  Serum CRP plays a major role in stratifying the patients for early aggressive 
intervention of acute pancreatitis to reduce morbidity and mortality. 
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ANNEXURE 
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                                       CASE   PROFORMA 
                                                       
Name:                                     Age/SEX:                   IP.NO:        UNIT:                                  
 
Date of admission:                                Date of Discharge: 
1. COMPLAINTS: 
a. Pain Abdomen 
         i) Duration                                                 ii) Mode of onset  
        iii) Site of pain                                          IV) Nature 
v) Radiation                                              VI) Shifting of pain 
vii) Aggravating / Relieving factors 
b. Vomiting 
i) Duration                                                  ii) Frequency 
 iii) Vomitus: Bilious / Blood / Faecal / otherwise. 
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 c. Fever 
         i) Duration      ii) Degree 
 
iii) Chills / Rigors 
d. Distension of abdomen 
 i) Present / absent: 
ii) Duration (if present): 
e. Bowel symptoms. 
 
i) Diarrhoea               ii) Constipation  
iii)Hematemesis/Melaena 
f. H/o reduced / nil urine output. 
 g. Other complaints (if any): 
2. PAST HISTORY: 
         a) H/o Previous operation 
         b) H/o Trauma 
         c) Any comorbid illness:         
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SHT/DM/TB/COPD/CAD. 
3. PERSONAL HISTORY: 
a) Diet : Mixed / Vegetation  
b) Appetite: Good / Impaired 
c) Habits: Smoker / Alcoholic 
 
4. FAMILY HISTORY: 
         Any other member of the family suffered from similar disease 
5. GENERAL PHYSICAL EXAMINATION: 
 a) Vital signs: 
Pulse:                                                                     Blood Pressure: 
 Temperature:                                                          Respiratory rate: 
b) Built and Nutrition: 
c) State of hydration 
d) Anaemia / Jaundice / Pedal edema / Lymphadenopathy 
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6. EXAMINATION OF THE ABDOMEN 
a) Inspection 
1. Shape                                                              2.Umbilicus 
3. Skin                                                                 4. Movement with respiration 
5. Visible veins                                                    6. Visible pulsation 
7. Hernial orifices                                                8. External genitalia 
9. Distension 
 
b) Palpation: 
1. Site of tenderness                                             2. Guarding / Rigidity 
3. Whether liver / spleen palpable 
 c) Percussion 
Liver dullness obliterated 
d) Auscultation 
Bowel sounds: Present / Absent 
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 e) Per rectal examination 
7. EXAMINATION OF OTHER 
SYSTEMS 
a. Cardiovascular system 
 b. Respiratory system 
c. Nervous system 
8. INVESTIGATION 
Blood investigations: 
1.Hb%                           TC                                               Blood Group 
2. Urine                        Sug                             Alb                        Micro 
3. RBS, Urea, Creatinine, Serum electrolytes, Serum amylase, Serum lipase, Serum 
CRP, Arterial blood gas analysis 
4.Special: X-ray abdomen (Erect / lateral decubitus) 
                 X-ray Chest PA view 
5. USG abdomen & pelvis 
6. CT abdomen & pelvis 
9. CLINICAL DIAGNOSIS 
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10. MANAGEMENT 
Medical  Management 
 Pre operative treatment 
 Operative details  
  Post operative management 
11. FINAL DIAGNOSIS 
12. COMPLICATIONS 
13. OUTCOME  
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MASTER CHART 
S.NO NAME AGE/SEX IP NO DOA DOD/AMA/DEATH SR. 
AMYLASE 
IU/L 
APACHEII 
SCORE 
SR. 
CRP 
mg/L 
1 PANCHAVARNAM 65/F 50621 03.10.15 12.10.15/DIS 625 17 152 
2 SELVAKUMAR 35/M 51236 06.10.15 27.10.15/DIS 860 10 165 
3 TAMILSELVAN 45/M 52218 08.10.15 19.10.15/DIS 608 13 198 
4 BALACHANDRAN 51/M 53640 26.10.15 06.11.15/DIS 436 13 151 
5 RAJARAJAN 30/M 54263 02.11.15 14.11.15/DIS 520 7 144 
6 BALAN 35/M 58719 06.11.15 21.11.15/DIS 632 9 153 
7 NATARAJAN 71/M 58958 06.11.15 13.11.15/DEATH 726 24 161 
8 BOOPATHY 43/M 59102 09.11.15 26.11.15/DIS 1032 10 153 
9 PITCHAIKANNU 44/M 59626 09.11.15 24.11.15/DIS 638 
 
9 155 
10 SUNDARESAN 70/M 59784 09.11.15 17.11.15/DEATH 1250 28 157 
11 RAJAPANDI 26/M 59906 09.11.15 16.11.15/DIS 216 9 119 
12 VENKATESH 34/M 61252 12.11.15 14.11.15/AMA 724 8 151 
13 BALACHANDAR 50/M 61528 13.11.15 23.11.15/DIS 325 9 119 
14 KUMAR 55/M 64206 15.11.15 02.12.15/DIS 1429 16 176 
15 ALAGESAN 29/M 65122 16.11.15 30.11.15/DIS 376 6 124 
16 KALIYAMOORTHY 35/M 65848 18.11.15 29.11.15/DIS 173 7 68 
17 SHANMUGAVEL 28/M 68456 18.11.15 28.11.15/DIS 455 7 113 
18 RAMESH 37/M 68975 18.11.15 26.11.15/DIS 255 8 108 
19 SURESH 30/M 69802 21.11.15 29.11.15/DIS 450 9 151 
20 PERIYASAMY 47/M 69865 21.11.15 02.12.15/DIS 652 12 159 
21 RAJA 42/M 69902 23.11.15 05.12.15/DIS 1520 18 162 
22 SELVARAJ 33/M 75210 30.11.15 12.12.15/DIS 198 7 84 
23 KASINATHAN 35/M 79620 05.12.15 19.12.15/DIS 320 7 129 
24 MURUGESAN 50/M 80546 09.12.15 23.12.15/DIS 480 9 151 
25 JAYAKUMAR 35/M 84230 14.12.15 28.12.15/DIS 240 6 130 
26 SARAVANAN 29/M 89745 19.12.15 26.12.15/DIS 180 3 95 
27 RAJESH 28/M 90123 21.12.15 30.12.15/DIS 362 4 116 
28 ANTHONIRAJ 38/M 95102 23.12.15 01.01.16/DIS 154 5 78 
29 CHANDRAMOHAN 37/M 98745 25.12.15 05.01.16/DIS 168 6 86 
30 ULAGANATHAN 40/M 99156 25.12.15 09.01.16/DIS 980 9 154 
31 MAHALINGAM 45/M 10241 27.12.15 14.01.16/DIS 236 8 112 
32 SUBBAIYAN 41/M 15201 29.12.15 10.01.16/DIS 330 5 106 
33 SUBRAMANI 30/M 1025 05.01.16 16.01.16/DIS 675 10 152 
34 PURUSOTHRAJ 38/M 1536 11.01.16 29.01.16/DIS 1275 10 160 
35 NOORJAHAN 65/F 1856 15.01.16 29.01.16/DIS 395 14 120 
36 THIRUGNAGAM 26/M 1965 16.01.16 02.02.16/DIS 534 8 152 
37 PANDIDURAI 55/M 1994 18.01.16 31.01.16/DIS 859 14 153 
38 SATHISH 34/M 2013 24.01.16 14.02.16/DIS 1086 4 162 
39 ARUNRAJ 39/M 2145 28.01.16 19.02.16/DIS 1032 5 158 
100 
 
40 BOOPATHI 42/M 2235 01.02.16 03.03.16/DIS 1280 11 168 
41 SARAVANAN 43/M 2531 15.02.16 25.02.16/DIS 436 8 151 
42 HARIHARAN 40/M 2687 19.02.16 05.03.16/DIS 424 8 152 
43 VASUKI 40/F 2745 23.02.16 12.03.16/DIS 386 4 136 
44 SHANMUGAVEL 28/M 4920 25.03.16 13.03.16/DIS 410 5 142 
45 SELVI 32/F 5201 06.04.16 26.04.16/DIS 234 4 116 
46 GUNASEKARAN 37/M 6987 26.04.16 09.05.16/DIS 1216 9 166 
47 VADIVEL 40/M 7832 05.05.16 21.05.16/DIS 287 5 120 
48 PALANISAMY 29/M 8984 30.05.16 12.06.16/DIS 687 5 156 
49 KALA 40/F 9520 16.06.16 29.06.16/DIS 256 6 104 
50 MURUGAN 48/M 10654 29.06.16 10.07.16/DIS 940 13 161 
51 KUMARESAN 45/M 15874 19.07.16 03.08.16/DIS 510 15 157 
52 VELAMMAL 52/F 19380 05.08.16 23.08.16/DIS 435 12 153 
53 GANDHI 53/M 25016 16.08.16 05.09.16/DIS 840 14 152 
54 PATTAMMAL 63/F 39523 31.08.16 14.09.16/AMA 829 13 156 
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